Literature DB >> 27686255

Altered regulation of the Spry2/Dyrk1A/PP2A triad by homocysteine impairs neural progenitor cell proliferation.

Luis G Rabaneda1, Noelia Geribaldi-Doldán2, Maribel Murillo-Carretero2, Manuel Carrasco2, José M Martínez-Salas2, Cristina Verástegui3, Carmen Castro4.   

Abstract

Hyperhomocysteinemia reduces neurogenesis in the adult mouse brain. Homocysteine (Hcy) inhibits postnatal neural progenitor cell (NPC) proliferation by specifically impairing the fibroblast growth factor receptor (FGFR)-Erk1/2-cyclin E signaling pathway. We demonstrate herein that the inhibition of FGFR-dependent NPC proliferation induced by Hcy is mediated by its capacity to alter the cellular methylation potential. Our results show that this alteration modified the expression pattern and activity of Sprouty2 (Spry2), a negative regulator of the above mentioned pathway. Both elevated concentrations of Hcy and methyltransferase activity inhibition induced Spry2 promoter demethylation in NPC cultures leading to a sustained upregulation of the expression of Spry2 mRNA and protein. In addition, protein levels of two kinases responsible for Spry2 activation/deactivation were altered by Hcy: Spry2 kinase Dyrk1A levels diminished while Spry2 phosphatase PP2A increased, leading to changes in the phosphorylation pattern, activity and stability of Spry2. In conclusion, Hcy inhibits NPC proliferation by indirect mechanisms involving alterations in DNA methylation, gene expression, and Spry2 function, causing FGFR signaling impairment.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dyrk1A; PP2A; Spry2; homocysteine; neural progenitor cells; neurogenesis

Mesh:

Substances:

Year:  2016        PMID: 27686255     DOI: 10.1016/j.bbamcr.2016.09.018

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

1.  Combined assessment of DYRK1A, BDNF and homocysteine levels as diagnostic marker for Alzheimer's disease.

Authors:  N Janel; P Alexopoulos; A Badel; F Lamari; A C Camproux; J Lagarde; S Simon; C Feraudet-Tarisse; P Lamourette; M Arbones; J L Paul; B Dubois; M C Potier; M Sarazin; J M Delabar
Journal:  Transl Psychiatry       Date:  2017-06-20       Impact factor: 6.222

2.  Vitamin D deficiency as a potential risk factor for accelerated aging, impaired hippocampal neurogenesis and cognitive decline: a role for Wnt/β-catenin signaling.

Authors:  Ricardo Gómez-Oliva; Noelia Geribaldi-Doldán; Samuel Domínguez-García; Livia Carrascal; Cristina Verástegui; Pedro Nunez-Abades; Carmen Castro
Journal:  Aging (Albany NY)       Date:  2020-06-17       Impact factor: 5.682

3.  A novel PKC activating molecule promotes neuroblast differentiation and delivery of newborn neurons in brain injuries.

Authors:  Samuel Domínguez-García; Noelia Geribaldi-Doldán; Ricardo Gómez-Oliva; Felix A Ruiz; Livia Carrascal; Jorge Bolívar; Cristina Verástegui; Monica Garcia-Alloza; Antonio J Macías-Sánchez; Rosario Hernández-Galán; Pedro Nunez-Abades; Carmen Castro
Journal:  Cell Death Dis       Date:  2020-04-22       Impact factor: 8.469

4.  Effects of classical PKC activation on hippocampal neurogenesis and cognitive performance: mechanism of action.

Authors:  Samuel Domínguez-García; Ricardo Gómez-Oliva; Noelia Geribaldi-Doldán; Carmen Hierro-Bujalance; Marta Sendra; Félix A Ruiz; Livia Carrascal; Antonio J Macías-Sánchez; Cristina Verástegui; Rosario Hernández-Galán; Mónica García-Alloza; Pedro Nunez-Abades; Carmen Castro
Journal:  Neuropsychopharmacology       Date:  2020-12-17       Impact factor: 7.853

5.  Epigenetic DNA Modifications Upregulate SPRY2 in Human Colorectal Cancers.

Authors:  Alexei J Stuckel; Shuai Zeng; Zhen Lyu; Wei Zhang; Xu Zhang; Urszula Dougherty; Reba Mustafi; Qiong Zhang; Trupti Joshi; Marc Bissonnette; Samrat Roy Choudhury; Sharad Khare
Journal:  Cells       Date:  2021-10-02       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.